For Lab R&D Uses Only

Purity:               >98% (HPLC)

Product Description:

The S-enantiomer of Sunvozertinib, showing 51.2 nM, 51.9 nM, 1 nM, and 21.2 nM against EGFR exon 20 NPH and ASV insertions, EGFR L858R/T790M mutation and Her2 exon20 YVMA insertion, respectively, also inhibiting BTK

References:

1) https://www.tandfonline.com/doi/abs/10.1080/03007995.2022.2083326

2) https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-21-1615/694369/Sunvozertinib-a-selective-EGFR-inhibitor-for

Analytical data

Price & Availability